Persistent Asset Partners »

Vir Biotechnology shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $383k 64k 6.03

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Vir Biotechnology

BlackRock
Sb Investment Advisers
Arch Venture Corp
Vanguard Group
State Street Corporation
FMR
Dimensional Fund Advisors
OrbiMed Advisors
Geode Capital Management
Goldman Sachs Group
Millennium Management
Standard Life Aberdeen
Hudson Bay Capital Management
Candriam Luxembourg S.C.A.
Charles Schwab Investment Management

View all funds holding Vir Biotechnology